Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX)


$4.39
+0.1640 ( +3.88% ) 41.4K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open


$4.39

Previous close


$4.23

Volume


41.4K

Market cap


$9.82M

Day range


$3.94 - $4.45

52 week range


$3.22 - $15.75

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 56 May 07, 2024
8-k 8K-related 16 May 07, 2024
8-k 8K-related 17 May 02, 2024
10-k/a Quarterly Reports 16 Apr 26, 2024
8-k 8K-related 37 Apr 25, 2024
8-k 8K-related 16 Apr 18, 2024
8-k 8K-related 18 Apr 10, 2024
8-k 8K-related 15 Apr 08, 2024
8-k 8K-related 17 Mar 27, 2024
8-k 8K-related 38 Mar 25, 2024

Latest News